FDA approves ZITUVIMET by Zydus Lifesciences for Type 2 diabetes treatment
Zydus Lifesciences Limited has achieved a significant milestone with the U.S. Food and Drug Administration (FDA) granting approval for ZITUVIMET, a combination of Sitagliptin and ... Read More
FDA approves Zydus Lifesciences’ ZITUVIO tablets for Type 2 diabetes
Zydus Lifesciences Limited announced today that the U.S. Food and Drug Administration (FDA) has granted approval for its New Drug Application (NDA) for ZITUVIO (Sitagliptin) ... Read More